OBJECTIVE: To evaluate the effectiveness of a diabetic foot risk classification system by the International Working Group on the Diabetic Foot to predict clinical outcomes. RESEARCH DESIGN AND METHODS: A total of 225 diabetic patients were initially evaluated as part of a prospective case-control study at the University of Texas Health Science Center at San Antonio. Complete records were available for 213 patients for follow-up evaluation after 29 months. Upon enrollment, subjects were stratified into four risk groups based on the presence of risk factors according to the consensus of the International Working Group on the Diabetic Foot. Group 0 consisted of subjects without neuropathy, group 1 consisted of patients with neuropathy but without deformity or peripheral vascular disease (PVD), group 2 consisted of subjects with neuropathy and deformity or PVD, and group 3 consisted of patients with a history of foot ulceration or a lower-extremity amputation. RESULTS: Upon enrollment, patients in higher-risk groups had longer duration of diabetes, worse glycemic control, vascular and neuropathic variables, and more systemic complications of diabetes. During 3 years of follow-up, ulceration occurred in 5.1, 14.3, 18.8, and 55.8% of the patients in groups 0, 1, 2, and 3, respectively (linear-by-linear association, P < 0.001). All amputations were found in Groups 2 and 3 (3.1 and 20.9%, P < 0.001). CONCLUSIONS: The foot risk classification of the International Working Group on the Diabetic Foot predicts ulceration and amputation and can function as a tool to prevent lower-extremity complications of diabetes.
OBJECTIVE: To evaluate the effectiveness of a diabetic foot risk classification system by the International Working Group on the Diabetic Foot to predict clinical outcomes. RESEARCH DESIGN AND METHODS: A total of 225 diabeticpatients were initially evaluated as part of a prospective case-control study at the University of Texas Health Science Center at San Antonio. Complete records were available for 213 patients for follow-up evaluation after 29 months. Upon enrollment, subjects were stratified into four risk groups based on the presence of risk factors according to the consensus of the International Working Group on the Diabetic Foot. Group 0 consisted of subjects without neuropathy, group 1 consisted of patients with neuropathy but without deformity or peripheral vascular disease (PVD), group 2 consisted of subjects with neuropathy and deformity or PVD, and group 3 consisted of patients with a history of foot ulceration or a lower-extremity amputation. RESULTS: Upon enrollment, patients in higher-risk groups had longer duration of diabetes, worse glycemic control, vascular and neuropathic variables, and more systemic complications of diabetes. During 3 years of follow-up, ulceration occurred in 5.1, 14.3, 18.8, and 55.8% of the patients in groups 0, 1, 2, and 3, respectively (linear-by-linear association, P < 0.001). All amputations were found in Groups 2 and 3 (3.1 and 20.9%, P < 0.001). CONCLUSIONS: The foot risk classification of the International Working Group on the Diabetic Foot predicts ulceration and amputation and can function as a tool to prevent lower-extremity complications of diabetes.
Authors: Bijan Najafi; Hooman Mohseni; Gurtej S Grewal; Talal K Talal; Robert A Menzies; David G Armstrong Journal: J Diabetes Sci Technol Date: 2017-05-17
Authors: Elbert S Huang; Qi Zhang; Sydney E S Brown; Melinda L Drum; David O Meltzer; Marshall H Chin Journal: Health Serv Res Date: 2007-12 Impact factor: 3.402
Authors: Suzanne Av van Asten; Daniel C Jupiter; Moez Mithani; Javier La Fontaine; Kathryn E Davis; Lawrence A Lavery Journal: Int Wound J Date: 2016-03-08 Impact factor: 3.315
Authors: Lawrence A Lavery; Nathan A Hunt; Javier Lafontaine; Cory L Baxter; Agbor Ndip; Andrew J M Boulton Journal: Diabetes Care Date: 2010-04-27 Impact factor: 19.112
Authors: Elbert S Huang; Michael O'Grady; Anirban Basu; Aaron Winn; Priya John; Joyce Lee; David Meltzer; Craig Kollman; Lori Laffel; William Tamborlane; Stuart Weinzimer; Tim Wysocki Journal: Diabetes Care Date: 2010-03-23 Impact factor: 17.152
Authors: Reginald Alex; Benjamin Ratnaraj; Blessed Winston; D Nathaniel Samson Devakiruba; Clarence Samuel; Jacob John; Venkata Raghava Mohan; Jasmine Helan Prasad; Ks Jacob Journal: Indian J Community Med Date: 2010-01